UC Riverside researcher develops novel method to grow human embryonic ...( RIVERSIDE Calif. The majority of re...)

RIVERSIDE, Calif. The majority of researchers working with human embryonic stem cells (hESCs) cells which produce any type of specialized adult cells in the human body use animal-based materials for culturing the cells. But because these materials are animal-based, they could transmit viruses and other pathogens to the hESCs, making the cells unsuitable for medical use.

Now, a stem-cell scientist at UC Riverside has devised a method of growing hESCs in the lab that uses no animal-derived materials an important advance in the use of hESCs for future medical purposes.

Because of their tremendous potential, hESCs are considered promising sources for future cell therapy to treat diseases such as Parkinson's disease and diabetes mellitus.

Noboru Sato, an assistant professor of biochemistry, developed the new method, which is not only cleaner and easier to use than conventional methods of culturing hESCs but also results in hESCs whose pluripotency the potential to differentiate into any of the specialized cells of the body such as neurons, cardiac muscles, and insulin-producing cells is uncompromised.

Currently in labs worldwide, many researchers grow hESCs on Matrigel-coated culture plates, Matrigel being the trade name for a gelatinous extract, taken from mouse tumor cells, that contains extracellular matrices (ECMs), made up of special proteins. The Matrigel coating provides the scaffolding to which the hESCs first attach and then grow in undifferentiated colonies before differentiating into specialized cells.

"The development of animal-free coating methods for hESCs still remains a major challenge due to the complexity of ECMs and insufficient knowledge about how hESCs control cell-cell and cell-ECM interactions," explained Sato, who led the research project.

His lab identified a specific signaling pathway, called Rho-Rock, which the
'/>"/>